Skip to main content
NIH funding notice PAR-20-319

NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional)

Closed on October 14, 2022.

Posted
February 9, 2021
Close date
October 14, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,081,173 in first-year total cost, median $1,081,173.

Most frequent study sections

  1. Special Emphasis Panel[ZEY1 VSN (06)]1

Most frequent institutions

  1. UNIVERSITY OF ILLINOIS AT CHICAGO1
Competing awards under PAR-20-319 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Alleviation of ER stress as a translational strategy to curb ocular viral infections1R24EY033598-01DATE, ABHIJIT ASHUKLA, DEEPAKUNIVERSITY OF ILLINOIS AT CHICAGO, IL$1,081,173ZEY1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.